Dose-Dependent Changes In Pharmacokinetic And Pharmacodynamic Profiles Of Met409, A Sustained Fxr Agonist, After 12 Weeks Of Treatment In Patients With Nash

HEPATOLOGY(2020)

引用 0|浏览12
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要